Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A(2025) The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases Ther Adv Med Oncol, 17, 17588359251332473 DOI 10.1177/17588359251332473, PubMed 40297622
Longva AS, Berg K, Weyergang A(2024) Corrigendum: Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment Front Immunol, 14, 1359973 DOI 10.3389/fimmu.2023.1359973, PubMed 38264651
Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital – Radiumhospitalet P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway Phone: +47-22781481 E mail: anette.weyergang@rr-research.no
